Rep. Katie Porter @RepKatiePorter
The fast-track approval process should be used when a drug shows promise, not as a backup when test results are too lackluster for the regular process. Cozy relationships—not science—may have led to Aduhlem's approval, so I'm calling for an investigation. https://t.co/kMt3SBVgho — PolitiTweet.org